Brief: HemoHim Manufacturer Kolmar BNH Receives NAI Classification From US FDA
21/10/2024 16:37
Oct 21 (Reuters) - KolmarBNH Co Ltd 200130.KQ :
* HEMOHIM MANUFACTURER KOLMAR BNH RECEIVES NAI
CLASSIFICATION FROM
THE US FDA
Source text for Eikon: ID:nBwbH3pMZa
Further company coverage: 200130.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on KolmarBNH
See all newsQ1 2026 Operating Profit Up 289.95% QoQ To 10 Billion Won
Brief: Kolmarbnh To Divest All Of Its Shares In Affiliate Kolmask Co Ltd
Brief: Kolmar Bnh Expects To Generate Operating Profit Of 32 Billion Won This Year
Brief: Kolmar Bnh April Operating Profit 3.6 Billion Won, Up 49.7% From Year Earlier
Brief: HemoHim Manufacturer Kolmar BNH Receives NAI Classification From US FDA